Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aschenbrenner

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
The American Journal of Nursing|October 21, 2021
Statins No Longer Contraindicated in PregnancyDiane S Aschenbrenner
The American Journal of Nursing|January 27, 2022
Drug Wins Designation as a Biosimilar Product to HumiraDiane S Aschenbrenner
The American Journal of Nursing|January 27, 2022
FDA Warns Against Using Needle-Free Injection Devices For Dermal FillersDiane S Aschenbrenner
The American Journal of Nursing|January 27, 2022
New Naloxone Concentration Treats Opioid OverdoseDiane S Aschenbrenner
The American Journal of Nursing|May 19, 2021
New Drug Protects Against Myelosuppression Secondary to Lung Cancer ChemotherapyDiane S Aschenbrenner
The American Journal of Nursing|December 23, 2021
New Indication for CabozantinibDiane S Aschenbrenner
The American Journal of Nursing|January 26, 2023
First Drug for Treating Hepatorenal SyndromeDiane S Aschenbrenner
The American Journal of Nursing|June 22, 2021
New Indication for RilonaceptDiane S Aschenbrenner
The American Journal of Nursing|June 23, 2022
New Approved Use for KeytrudaDiane S Aschenbrenner
The American Journal of Nursing|April 20, 2023
Safe Practices for Medication Administration via Enteral TubesDiane S Aschenbrenner
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
The American Journal of Nursing|October 21, 2021
Statins No Longer Contraindicated in PregnancyDiane S Aschenbrenner
The American Journal of Nursing|January 27, 2022
Drug Wins Designation as a Biosimilar Product to HumiraDiane S Aschenbrenner
The American Journal of Nursing|January 27, 2022
FDA Warns Against Using Needle-Free Injection Devices For Dermal FillersDiane S Aschenbrenner
The American Journal of Nursing|January 27, 2022
New Naloxone Concentration Treats Opioid OverdoseDiane S Aschenbrenner
The American Journal of Nursing|May 19, 2021
New Drug Protects Against Myelosuppression Secondary to Lung Cancer ChemotherapyDiane S Aschenbrenner
The American Journal of Nursing|December 23, 2021
New Indication for CabozantinibDiane S Aschenbrenner
The American Journal of Nursing|January 26, 2023
First Drug for Treating Hepatorenal SyndromeDiane S Aschenbrenner
The American Journal of Nursing|June 22, 2021
New Indication for RilonaceptDiane S Aschenbrenner
The American Journal of Nursing|June 23, 2022
New Approved Use for KeytrudaDiane S Aschenbrenner
The American Journal of Nursing|April 20, 2023
Safe Practices for Medication Administration via Enteral TubesDiane S Aschenbrenner
Pageof 9